Global Patent Index - EP 4110311 A1

EP 4110311 A1 20230104 - THERAPY

Title (en)

THERAPY

Title (de)

THERAPIE

Title (fr)

THÉRAPIE

Publication

EP 4110311 A1 20230104 (EN)

Application

EP 21708345 A 20210222

Priority

  • GB 202002639 A 20200225
  • GB 2021050429 W 20210222

Abstract (en)

[origin: WO2021170982A1] Cinnamic acid and/or pharmaceutically acceptable salts thereof, and/or cinnamaldehyde, for use in the treatment and/or prevention of a disease or condition associated with hyperglycinemia and/or hyperammonemia.

IPC 8 full level

A61K 31/11 (2006.01); A61K 31/192 (2006.01); A61P 43/00 (2006.01)

CPC (source: EP)

A61K 31/11 (2013.01); A61K 31/192 (2013.01); A61P 43/00 (2017.12)

Citation (search report)

See references of WO 2021170982A1

Designated contracting state (EPC)

AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

Designated extension state (EPC)

BA ME

Designated validation state (EPC)

KH MA MD TN

DOCDB simple family (publication)

WO 2021170982 A1 20210902; EP 4110311 A1 20230104; GB 202002639 D0 20200408

DOCDB simple family (application)

GB 2021050429 W 20210222; EP 21708345 A 20210222; GB 202002639 A 20200225